Company intelligence / Profile preview

Heart Repair Technologies

San Jose, California, United Statesmpo-mag.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Heart Repair Technologies has developed a surgical mitral repair device with CE Mark approval since 2017. The company is now advancing a minimally invasive transcatheter version—the TAB System—for functional mitral and tricuspid regurgitation. Acute animal studies have been completed successfully, with chronic animal safety studies underway as of mid-to-late 2024. First-in-human trials are planned or ongoing for the transcatheter system, targeting patients with significant unmet needs in heart failure due to valve regurgitation. The company holds broad intellectual property coverage across its technology.

Therapeutic areas: Cardiovascular
Modalities: DeviceTranscatheter technologySurgical implant (predicate device)
Industry: Implantable Medical Devices

Partnerships

None publicly disclosed; strategic partnerships likely sought but not named.

Beyond the preview

Go deeper on Heart Repair Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heart Repair Technologies.

Explore the full profile